Noninvasive Ventilation Protocol Development by Tinsman, Janise Pierce
Running head:  NONINVASIVE VENTILATION PROTOCOL DEVELOPMENT  
  
 
 
 
 
Noninvasive Ventilation Protocol Development 
A Scholarly Project  
Submitted to the  
Faculty of Liberty University 
in partial fulfillment of 
the requirements for the degree  
of Doctor of Nursing Practice 
By 
Janise P. Tinsman 
Liberty University 
Lynchburg, VA 
October 2019 
 
 
 
 
 
 
2 
NONINVASIVE VENTILATION PROTOCOL DEVELOPMENT 
Noninvasive Ventilation Protocol Development 
A Scholarly Project  
Submitted to the  
Faculty of Liberty University 
in partial fulfillment of 
the requirements for the degree  
of Doctor of Nursing Practice 
By 
Janise P. Tinsman 
Liberty University 
Lynchburg, VA 
August 2019 
 
 
 
Scholarly Project Chair Approval:  
 
Cynthia Goodrich, EdD, MSN, RN, CNE 
 
 
  
3 
NONINVASIVE VENTILATION PROTOCOL DEVELOPMENT 
Abstract 
Endotracheal intubation results in many serious complications including regurgitation, vocal 
cord paralysis, and death.  Noninvasive ventilation using bi-level positive airway pressure has 
been shown to provide the necessary support without intubation and is also associated with better 
outcomes if trialed prior to endotracheal intubation.  A noninvasive ventilation protocol was 
applied in a rural acute care facility. Results: The average length of stay for acute respiratory 
failure decreased from 5.32 to 4.44 days, while intubations fell from 41.9% to zero, and mortality 
fell from 9.7% to zero during the pilot period.  Five cases met criteria for noninvasive 
ventilation, and three received prompt intervention with lengths of stay of two to four days.  One 
did not have CO2 levels assessed upon admission resulting in delayed noninvasive ventilation, 
and a twelve-day stay.  The fifth refused the therapy and was discharged on hospice. 
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Noninvasive Ventilation Protocol Development 
Section One 
Background 
 Endotracheal intubation (ETI) is associated with many serious complications including 
hypoxemia, laryngospasm, airway edema, vocal cord paralysis, regurgitation, cardiovascular 
collapse, and even cardiac arrest.  Patients that present to the hospital in acute respiratory distress 
or failure have been shown to respond well to noninvasive ventilation (NIV), decreasing the risk 
of serious trauma from intubation.  The Canadian Critical Care Society has developed guidelines 
for NIV trials prior to invasive ETI.  The Infectious Disease Society of America (IDSA) and the 
American Thoracic Society (ATS) joint guidelines for community acquired pneumonia (CAP) 
includes a recommendation for NIV protocols.  NIV has been proven useful in the management 
of acute respiratory failure (ARF) associated with chronic obstructive pulmonary disease 
(COPD) and cardiogenic pulmonary edema (CPE).  Development of NIV protocols led to a 
decrease in the number of ETIs performed, decreasing the trauma associated with this procedure.  
Use of NIV often resolves the respiratory failure, allows for patient communication and oral 
intake of nutrition, and supports the patient’s respirations rather than taking over the work of 
breathing. 
 The facility under study began investigating its respiratory care practices related to a 
report of higher than expected 30-day pneumonia mortality rates.  A gap analysis of the 
IDSA/ATS guidelines was conducted, with multiple gaps found, including the lack of NIV 
protocols, which could impact not only pneumonia survival rates, but COPD and CPE outcomes 
as well.  NIV is shown to be effective in ARF with hypoxia, a decreased level of oxygen in the 
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blood, and hypercapnia, an elevated level of carbon dioxide (CO2) in the blood.  These levels are 
most accurately measured via arterial blood gas (ABG) measurement. 
 Historical data was collected on 31 admissions with a diagnosis of ARF between 
December 27, 2018, and April 12, 2019.  Fifteen patients reviewed received ETI with twelve of 
these occurring in the Emergency Department (ED).  The twelve ED intubations recorded two 
NIV trials prior to intubation, and one patient refusing to keep the NIV mask in place prior to 
intubation. One patient arrived in the ED already intubated by the Emergency Medical Services 
team.  One patient was intubated in the OR and arrested in the OR.  One patient was in the 
intensive care unit (ICU) and on NIV for two days prior to intubation.  One patient who was not 
hypercapnic in the beginning of their course of treatment placed on NIV for five days with no 
follow up ABGs and arrested on the fifth day with a PaCO2 of 81.7, with normal values for 
PaCO2 at 35-45.  Four patients with hypercapnia were managed with NIV alone and were not 
intubated.  Establishment of a protocol for monitoring patient response to NIV could prevent the 
event described above, as periodic monitoring of ABGs would catch the change in PaCO2 to 
allow intervention before respiratory arrest.  Trialing of NIV when possible prior to ETI would 
reduce the potential damage from the invasive procedure and decrease LOS. 
Problem Statement  
 Lack of an NIV protocol can lead to inconsistent application of this therapy, placing 
patients at risk for failure to rescue or complications from unnecessary ETI.  NIV protocols 
provide guidelines for consideration of NIV as well as indications for ETI.  These guidelines will 
improve outcomes for patients in ARF. 
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Purpose of the Project 
 The purpose of the project is determination of NIV protocols to prompt for rapid 
application of this therapy in appropriate situations and reduction in the number ETIs for ARF.  
The NIV protocol is expected to reduce the rate of failure to rescue and ETI in adult ARF 
patients with improved patient outcomes, including decreased length of stay (LOS) and mortality 
rates. 
Clinical Question 
 For adult patients presenting to a rural Texas acute care facility with acute respiratory 
failure (ARF), will a noninvasive ventilation (NIV) protocol decrease the rate of failure to 
rescue, the number of endotracheal intubations (ETIs), length of stay (LOS), and mortality rates. 
Section Two: Literature Review 
Search Strategy  
A search was conducted using CINAHL, MEDLINE PLUS, the Cochrane Library, and 
ProQuest Health and Medical Collection databases.  Search terms included noninvasive 
ventilation (NIV), noninvasive positive pressure ventilation (NPPV), acute respiratory failure 
(ARF), endotracheal intubation (ETI), and protocols.  Twenty-one articles were selected and 
examined using the Melnyk Levels of Evidence Table.  Eighteen studies and articles were found 
to support the project.  Two were studies that were in progress with no results available at the 
time of the literature search, and three involved equipment or personnel not available in the 
facility of study.  
Critical Appraisal  
Six of the studies included were published between 2011 and 2013, with four of these 
being Level I systematic reviews or practice guidelines.  The remaining studies were published 
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in the past five years.  Nine of the studies included in the review are Level I evidence as 
systematic reviews, meta-analyses, or practice guidelines, seven of which support the use of NIV 
in reduction of ETI and mortality in ARF.  There are two Level II randomized controlled trials 
that address the issue but are ongoing with no results available.  Four Level IV cohort studies are 
included, two of which indicate ARF patients provided a trial of NIV prior to ETI experience 
better outcomes than patients intubated without NIV trial.  One Level V qualitative analysis is 
included which also supports NIV in the reduction of ETI.   Four Level VI studies are included, 
one supporting NIV for treatment of ARF in underlying COPD and CPE, one discussing 
humidification in NIV, one comparing individual physician controlled noninvasive positive 
pressure ventilation (iNPPV) and protocol-driven noninvasive positive pressure ventilation 
(pNPPV), and one examining the role of the physiotherapist in NIV management.  Two Level 
VII expert opinion articles were included supporting the need for NIV protocols and training of 
staff in appropriate use.   
Synthesis 
 NIV is shown to be associated with a decreased rate of ETI, protecting patients from the 
trauma involved in this invasive therapy (Digby, 2015; Liu, Zhao, & Tang, 2016; Osadnik et al., 
2017; Ouellette et al., 2017; Scala & Pisana, 2018).  NIV is supported for use in ARF in the 
presence of chronic illnesses such as COPD and CPE (Burns, Meade, Premji & Adhikari, 2013; 
Keenan et al., 2011; Stefan et al., 2018; Vargas et al., 2017).  Berg and Donnino (2012) support 
the use of NIV for pneumonia associated ARF, while Lim et al. (2012) found controversial data 
for use of NIV in asthmatic clients. Bersten (2011) and Equinas et al. (2014) support the need for 
protocols and staff training in the use of NIV.  Kikichi et al. (2011) investigated outcomes 
between individual physician-directed noninvasive positive pressure ventilation (iNPPV) and 
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protocol-based NPPV (pNPPV), finding pNPPV to reduce the time to intubation and to reduce 
group and hospital mortality.   
The remaining studies address specific aspects of NIV therapy that could inform 
development of an NIV protocol.  Alqahtani, Worsley, and Voegeli (2018) found that humidity 
in NIV increased the development of skin breakdown.  BaHammam, Singh, Gupta, Pandi, and 
Perunal (2018) found full-face and oronasal masks preferable to nasal masks in the acute stage, 
with weaning to oronasal appropriate after stabilization.  Brambilla et al., (2019) suggest a 
continuous positive airway pressure (CPAP) trial for hypoxic nonhypercapnic ARF, with shift to 
NPPV if response is poor.  Meeder, Tjan, and Zanten (2016) recommend an NPPV prior to ETI 
as those patients receiving NPPV prior to ETI had better outcomes than those initially intubated 
without NPPV.  Ouellette et al. (2017) recommend spontaneous breathing trials (SBT) for those 
intubated greater than 24 hours with CPAP, minimal sedation, and NIV post extubation to 
prevent weaning failure.  Ni, Wang, Tu, Liang, and Liang (2017) suggest that NPPV interface 
intolerance post extubation can be managed with sedation and analgesia.   
Four studies are not applicable to the proposed project.  Burns, Lelloch, Wisenbaum, 
Lessard, and Friedrich (2014) discussed the SmartCare automated weaning system that is not 
available at the facility of study.  Simonelli, Paneroni, and Vitacca (2013) discussed the role of 
the physiotherapist in NIV therapy, and no physiotherapists are available in the facility of study.  
The two randomized controlled trials described appropriate questions of interest but had not been 
completed at the time of the search. Therefore no evidence was available to inform the project. 
Conceptual Model  
The Iowa Model June 2015 Revision: Evidence-Based Practice to Promote Excellence in 
Health Care, hereafter referred to as the Iowa Model, was applied to the project.  The Iowa 
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Model consists of a triggering issue with a question to be explored.  A quality improvement team 
is then formed to address the question with deliberate consideration of the appropriate disciplines 
to be included on the team.  Collection of historical data within the facility connected with the 
practice question formed a comparison group for improvement.  Research into the body of 
evidence surrounding the practice question was done as described above to determine best 
practice.  The team designed and implemented a pilot practice change, monitored patient 
outcomes, and compared them to the historical data previously collected. 
The triggering issue for the project was the preliminary gap analysis identifying lack of a 
noninvasive ventilation (NIV) protocol.  The question to be explored was whether an NIV 
protocol would reduce the number of ETIs, mortality rates, and length of stay (LOS) for all adult 
ARF patients.  The NIV protocol development team (NIV-PDT) included the project leader, 
respiratory therapy department head, respiratory therapists, the chief hospitalist, the nurse 
manager of ICU, the nurse informaticist, the Chief Nursing Officer, and the Director of 
Operations.  A literature review was performed as described above informing the development of 
a protocol by the NIV-PDT. Historical data regarding NIV, ETI, and patient outcomes had been 
collected by the project leader for comparison against project outcomes. The pilot protocol 
developed by the team was approved and education of respiratory therapists, nurses, and 
physicians followed.  The protocol was implemented for eight weeks in the ED, ICU, and 
Medical/Telemetry units.  NIV, ETIs, LOS, and mortality rates for adult patients admitted with 
ARF were collected over the course of the pilot and reported upon conclusion of the pilot.  The 
results were provided to the pulmonary medicine director to inform any modifications desired for 
a standing protocol. Integration and sustainability of the NIV protocol will be achieved through 
policy revisions supporting the establishment of an official NIV protocol and policy for the 
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facility.  Dissemination of the results may occur at the corporate level for sister facilities within 
the corporation.  Results will also be presented as the project defense by the project leader and 
posted in the Liberty University Digital commons. 
Summary  
 The IDSA/ATS guidelines for CAP and the CCCS guidelines for NIV support the 
development of NIV protocols.  Recent research further supports preliminary NIV trials prior to 
ETI and standardization of care.  The IDSA/ATS gap analysis performed by the facility revealed 
the lack of a NIV protocol.  A quality improvement team was formed to address this gap and 
develop said protocol.  Improvement of patient outcomes, specifically decreased number of 
ETIs, LOS, and mortality rates for adult ARF patients, were monitored and compared to pre-
project data.  
Section Three: Methodology 
Design 
 The study was an evidence-based practice (EBP) project utilizing a quasi-experimental 
approach to gather and analyze data.  Examination of the effect of NIV protocols on the rate of 
ETI and mortality and LOS for adult ARF patients was performed.  Data gathered was shared 
during the project and upon completion.  Data was also compared to historical data collected 
before implementation of the protocol.  
Measurable Outcomes  
 The variables of interest include the rate of ETI, average LOS, and mortality rates for 
adult patients admitted with ARF.  The lack of NIV protocols has resulted in a variety of 
individual physician-directed methods of treatment rather than a standardized approach to care.  
Development of a protocol was expected to decrease ETIs, LOS, and mortality rates for adult 
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ARF patients.  The protocol was also expected to decrease the incidence of failure to rescue in 
this patient population. 
Setting  
The project was implemented in a rural Texas hospital with a 15-bed ED, 12 ICU beds 
and 36 Medical/Telemetry beds.  The organizational culture welcomes EBP initiatives and 
quality improvement projects.  Adults in ARF will first be seen in the ED and determination 
regarding ventilation and response to treatment evaluated.  The NIV protocol would be critical at 
this juncture of care.  NIV could continue in the ICU and Medical/Telemetry units necessitating 
protocols for these areas as well.  NIV is also used as part of the ETI weaning process in the 
ICU, and established standards could improve the patient experience and outcomes there.  
Permission to pursue the NIV protocol was granted by the facility and can be found in the 
appendix.   
Population  
 The population of study included all adult ARF patients treated in the facility during an 
eight-week period after protocol initiation.  Asthma patients were excluded due to lack of 
evidence of the efficacy of NIV in this population.  The hospitalists, along with the respiratory 
therapists, and nurses in ICU, ED, and Medical/Telemetry were educated regarding the protocol. 
Documentation indicating protocol implementation, along with ETI, LOS, and mortality for this 
population were evaluated.  
Ethical Considerations  
 The risk to the patients was reduced through implementation of the protocol, designed to 
initiate less invasive ventilation prior to ETI.  All ARF patients received this evidence-based 
standard of care, with the historical data serving as the control group. Decreased numbers of 
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ETIs reduces the complications seen with invasive intubation.  The project leader and Chair have 
completed the CITI training for the protection of human subjects. 
Data Collection  
 Chart reviews were performed to ascertain adherence to the pilot NIV protocol.  Patient 
response to NIV, incidence of ETI, LOS, and mortality rates were also gathered. Data was shared 
with the NIV-PDT upon project completion.  This data was compared to the historical data 
collected prior to the protocol. 
Tools  
 The major tool for the project is the NIV protocol developed by the NIV-PDT.  An audit 
tool for collection of data for ARF patients, including the ventilation support used, the LOS, and 
the mortality rate, was used for historical data collection.  ARF patient charts were audited with 
the same tool after initiation of the protocol.  An educational presentation was given to the 
hospitalist group providers, respiratory therapists, and nurses in ED, ICU, and 
Medical/Telemetry units regarding their roles, and the necessity for and implementation of the 
protocol. The ED providers group was new to the facility and just adjusting to their new 
environment and were not included in the education. 
Intervention  
 The lack of NIV protocols results in inconsistent care for adult ARF patients.  Education 
of providers, RTs, and nurses involved in implementation was provided regarding the use of the 
protocol and the rationale behind the development of the protocol.  Implementation of an NIV 
protocol developed by the NIV-PDT was performed over an eight-week period.   
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Data Analysis  
Historical and post pilot protocol data were analyzed using descriptive statistics to assist 
in finding trends that support the continued use of the protocol.  Implementation of the protocol 
was expected to decrease the number of ETIs and the associated complications.  ARF patient 
LOS and mortality were also expected to decrease with the protocol.  
Section Four: Results 
Descriptive Statistics 
The measurable outcomes of percentage of ETI, average LOS, and mortality were 
compared between the historical and pilot groups with the results displayed in Table 1.  There 
was improvement noted in all three measures among the pilot group. The percentage of ARF 
patients intubated in the historical group was 48.4%, while there were no intubations in the pilot 
group.  The average LOS for the historical group was 5.32 days, and the pilot group average 
LOS was 4.44 days.  There was a 9.7% mortality rate among the historical group, with no 
mortalities occurring in the pilot group. Of the thirty-six pilot patients, six were placed on 
hospice for end-of-life care, but there were no deaths during the acute inpatient stay.  The results 
support the use of protocols for respiratory and ventilatory support. 
 
Table 1 
Comparison of Measurable Outcomes  
Outcome      Historical   Pilot 
Percentage of endotracheal intubations  48.4%    0 
Average Length of Stay (LOS)   5.32 Days   4.44 Days 
Mortality rate      9.7%    0 
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______________________________________________________________________________ 
Protocol adherence and patient response were also monitored during the pilot.  Twelve of 
the thirty-six patients were hypercapnic, and five of those twelve were also acidotic, prompting 
for initiation of the NIV protocol.  BiPAP was initiated immediately for three of the five, with 
one patient refusing the therapy. The remaining patient did not have an ABG drawn until day 
four of the stay. On day five, Vapotherm, a warmed, humidified, and pressure regulated high-
flow nasal cannula delivery, was initiated, followed by BiPAP. The hospital course continued 
over seven more days before the patient was transferred to a long-term acute care (LTAC) 
facility. Table 2 displays the course of these five patients for whom the protocol applied. 
Table 2  
Protocol Applicable Patient Course 
 
Pt ID  pH PCO2 Support Recheck LOS Disposition 
______________________________________________________________________________ 
P-3 7.25 48 2L/NC  5 Hours 12 Transfer to LTAC 
P-7 7.22 72 BiPAP  2.5 Hours 4 Discharge with O2 
P-11 7.33 57.1 BiPAP  5 Hours 2 Home with Home Health 
P-26 7.30 87.5 3L/NC  17 Hours 3 Home on Hospice 
P-33  7.29 68.3 BiPAP  2 Hours 3 Home with trilogy for OSA 
_____________________________________________________________________________ 
The additional respiratory support therapy implemented in the pilot group known as 
Vapotherm was not addressed in the pilot protocol. Two pilot patients received Vapotherm 
alone, three received alternating Vapotherm and BiPAP, and three received BiPAP alone.  Only 
one of the hypercapnic, acidotic patients received this therapy as described above. 
Section Five: Discussion 
Implications for Practice  
 The results of this pilot project support the use of protocols for NIV and other respiratory 
support therapies.  Uniform application of evidence-based practice yields improved patient 
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outcomes, as well as improved team morale.  Consistent delivery of care removes uncertainty 
among team members regarding implementation and evaluation of care. Protocols for respiratory 
support allow for more rapid application of these therapies by the respiratory therapists and 
nurses, thus removing the time element of contacting a provider for orders. Treatment options 
such as NIV that have been shown to positively impact patient outcomes can be initiated upon 
initial assessment by respiratory therapists if the patient meets the set criteria.  Protocols should 
indicate time frames for evaluation of the patients and indications for continued therapy or 
consideration of ETI.  The historical group included a patient that was on BiPAP for five days 
without evaluation of respiratory status via arterial blood gases (ABGs). When this patient 
arrested, the PaCO2 was 81.7, well above the normal 35–45 range.  This could have been avoided 
if a protocol prompting for periodic evaluation of patients on ventilatory support had been in 
place.  During the interim between the historical study and the pilot project, a patient came into 
the emergency department with ARF and was placed on BiPAP.  When the admitting provider 
evaluated the patient, the patient was able to answer questions without evidence of respiratory 
distress, and the BiPAP was discontinued.  A few hours later, the patient arrested on the 
Medical/Telemetry unit.  A protocol that called for at least 12 hours of NIV therapy and a 
reassessment by ABGs prior to discontinuation could have prevented this situation as well. 
 The use of Vapotherm requires additional study and investigation.  There are very few 
studies regarding the use of this therapy in adults.  The recommendations for use are provided 
from studies performed by the manufacturer rather than an impartial researcher.  For the 
hypercapnic, acidotic patient, this therapy was found to be less effective than BiPAP.  The 
facility could perform their own study of the effectiveness of this therapy and develop guidelines 
for application of this intervention. 
19 
NONINVASIVE VENTILATION PROTOCOL DEVELOPMENT 
 Limitations of the project include the application in a single small facility with sample 
sizes less than forty patients for both groups.  The time frame of the historical data was during 
the first months of the year when there typically are more cases of respiratory infections; 
however, the protocol period evidenced a slightly higher number of ARF patients.  The small 
sample size of five ARF patients with both hypercapnia and acidosis limits applicability of 
results to further studies.  The pilot time frame was also limited to two months for data 
collection, further decreasing the generalizability of the results. 
Sustainability  
 The results of the study and research into appropriate use of the Vapotherm therapy have 
been shared with the pulmonary medical director.  A formal protocol is to be developed by the 
facility providers including the ED physicians and representatives from the respiratory therapy 
department.  The protocol will provide parameters for initiation of various oxygen/ventilatory 
support therapies.  Institution of such a policy will free respiratory therapists to initiate 
oxygen/ventilatory support without taking time to obtain an order from the providers. Patients 
will receive these critical therapies sooner and recovery times will be decreased. The protocol 
should also address evaluation parameters for patients with ventilatory support, allowing for 
weaning or adapting therapy according to individual patient response. 
Dissemination Plan  
 The NIV Protocol Project will be submitted to the Liberty University Scholars Crossing.  
A poster presentation and Podium presentations have also been prepared for sharing these 
results.  The results have been shared with the Director of Quality Management and Regulatory 
Compliance for report to the corporate superiors. The results may then be shared with sister 
20 
NONINVASIVE VENTILATION PROTOCOL DEVELOPMENT 
facilities within the corporation.  Poster and podium presentations have been prepared, as well as 
a manuscript for potential publication. 
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 Supports 
Practice 
Change  
Alqahtani, J. 
S., Worsley, P., 
& Voegeli, D. 
(2018) 
Determine the 
effect on 
humidification of 
CPAP the skin 
microclimate, 
barrier function, 
and risk of 
pressure ulcer 
development 
Fifteen healthy 
volunteers  
A crossover 
cohort design. 
Transepithelial 
water loss, skin 
hydration and 
pH at the bridge 
of the nose and 
both cheeks 
after both non-
humidified and 
humidified 
CPAP therapy 
Humidified NIV 
was shown to have 
a higher risk of 
breakdown and 
disruption of the 
interface, while 
non-humidified 
therapy resulted in 
elevated nasal 
discomfort 
Level VI  
Single 
descriptive 
study 
Small sample of 
only 15 healthy 
adults. Many 
who require NIV 
have multiple 
health challenges 
Yes. 
Withholding 
humidity could 
be included in 
the protocol  
 
 
BaHammam, 
A. S., Singh, T. 
D., Gupta, R., 
Pandi-Perumal, 
S. R., (2018)  
Investigation of 
different 
interfaces for NIV 
and their effect on 
treatment success, 
upper airway 
patency, mask 
fitting, and 
interface related 
problems 
80 studies 
comparing 
interfaces during 
NIV during 
acute respiratory 
failure ARF 
were reviewed 
and summarized 
Systematic 
review  
Oronasal and face 
masks are preferred 
for ARF. Fitting to 
prevent air leaks 
and skin irritation 
is needed for 
successful NIV 
therapy. Shifting to 
nasal mask may be 
done when 
stabilized, but 
patient preference 
must be accounted 
for. The helmet is a 
Level I 
Systematic 
review 
Multiple studies 
reviewed 
comparing 
multiple NIV 
interfaces 
Yes. 
Stabilization on 
Full face or 
oronasal mask 
for ARF could 
be included in 
the protocol 
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promising new 
interface for NIV. 
Berg, K. M., 
Donnino, M. 
W., (2012) 
Examination of 
the evidence 
supporting NIV, 
the potential 
dangers, and 
guidelines for use 
Forty-four 
studies/articles 
involving NIV 
in ARF were 
analyzed 
Systematic 
review 
The use of NIV in 
hypoxemia related 
to pneumonia 
resulted in 
significantly lower 
intubation rates, 
hospital mortality, 
and complications. 
Early initiation of 
NIV is most 
successful. The 
strongest evidence 
for use involves 
exacerbation of 
COPD, as many 
studies have 
focused on this 
disease process. 
Level I 
systematic 
review 
Includes the 
results of many 
RCTs and also 
meta-analyses 
Yes. NIV use 
in pneumonia 
is a significant 
piece of the 
protocol 
 
Bersten, A. D., 
(2011) 
Editorial based 
off Keenan study 
below 
Key points 
gleaned from 
guidelines for 
implementation 
of NIV 
Compilation of 
key points found 
in the referred 
review. 
Successful 
implementation of 
NIV requires 24-
hour availability of 
experienced team 
members and 
monitoring for 
failure to respond 
and intubation 
when indicated. 
Level VII 
Expert opinion 
of researcher 
Support for well-
trained team but 
presented as 
opinion 
Yes. Support 
for training of 
staff and 
providers in 
management of 
care 
 
Brambilla, A. 
M., et al., 
(2019) 
Evaluation of the 
use of NIV in 
ARF due to 
347 from 19 
centers in Italy 
experiencing 
Observational 
study of the 
treatment of 
CPAP more often 
used for hypoxemic 
nonhypercapnic 
Level IV  
Observational 
study of two 
The sample size 
and multiple 
center aspects of 
Yes. 
CPAP could be 
trialed with 
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pneumonia 
outside the ICU, 
and identification 
of in-hospital 
mortality risk 
factors  
ARF associated 
with pneumonia 
pneumonia 
patients with 
ARF and use of 
NIV. CPAP 
applied to 176 
patients and 
NPPV for 171. 
Patient blood 
gas results were 
monitored,  as 
well as in-
hospital 
mortality 
ARF. CPAP failure 
would often 
respond to NPPV 
and prevent the 
need for intubation. 
Mortality rates 
appeared to be 
associated with the 
patient’s baseline 
status. 
treatment 
options across 
19 facilities 
this study 
increase its 
validity. The 
authors concede 
that the facilities 
of study are 
experienced in 
the use of NIV. 
nonhypercapnic 
patients. 
Burns, K. E. 
A., Meade M. 
O., Premji A., 
Adhikari, N. K. 
J., (2013) 
Examination of 
studies involving 
weaning from 
intubation and 
mechanical 
ventilation to 
NPPV versus 
intermittent 
positive-pressure 
ventilation (IPPV) 
weaning.  
Reduction of 
mortality, 
weaning failure, 
ventilator-
associated 
pneumonia, ICU 
and total length of 
stay, duration of 
mechanical 
Sixteen studies 
analyzed by four 
researchers 
Systematic 
review 
NPPV significantly 
reduced mortality 
and weaning 
failure. ICU and 
hospital LOS was 
also reduced along 
with duration of 
mechanical and 
noninvasive 
ventilation. 
Reduced risk of 
VAP without 
increased risk of 
failure to wean or 
reintubation was 
also noted. 
Level I 
systematic 
review 
Sixteen RCTS 
were analyzed 
with 
predominantly 
COPD patients. 
Effects in other 
situations 
requiring 
ventilation 
should also be 
evaluated. 
Yes. 
Supports the 
use of NPPV as 
a method to 
reduce 
mortality and 
complications 
from intubation 
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ventilation of 
support, and 
adverse events. 
Burns, K. E. 
A., Lellouch, 
L., Nisenbaum, 
R., Lessard, M. 
R., Friedrich, J. 
O., (2014) 
Comparison of 
weaning times 
using automated 
weaning and 
spontaneous 
breathing trials 
(SBTs) versus 
non-automated 
weaning 
strategies in 
invasively 
ventilated 
critically ill 
adults. 
Time to 
successful 
intubation, first 
SBT and first 
successful SBT, 
mortality and 
VAP rates, and 
the LOS for ICU 
and hospital were 
also compared. 
10 trials with a 
total of 654 
participants 
were examined 
Systematic 
review 
Automated 
weaning via the 
SmartCare system 
decreased weaning 
time, time to 
successful 
extubation, and 
LOS in ICU, 
reducing the 
percentage of 
patients requiring 
mechanical 
ventilation for 7 or 
21 days.  These 
benefits were 
realized without 
increased risk of 
adverse events. 
Level I 
Systematic 
review 
Ten small trials 
with low to 
moderate quality 
of evidence were 
used to compile 
data. A larger 
trial, perhaps in 
multiple 
locations would 
have been 
preferable.  
No. This 
system is not 
available in the 
facility. 
Cabrini, L. et 
al., (2019) 
Evaluate early 
NIV for mild-
moderate ARF in 
non-ICU wards to 
prevent severe 
ARF. 
520 patients 
with 260 in each 
group 
randomized to 
receive NIV or 
treatment as 
Tracking of 
development of 
severe ARF, 28-
day mortality, 
LOS, the safety 
of NIV in non-
Trial is ongoing Level II RCT The sample size 
is adequate to 
inform practice 
The results of 
this study could 
inform the 
project but are 
not yet 
available. 
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usual for mild-
moderate ARF 
ICU 
environments 
Digby, G. C., 
et al., (2015) 
Description of 
NIV practice 
variation in the 
acute setting 
330 patients 
treated in 11 
Canadian 
tertiary care 
centers using 
NIV for ARF 
Collection of 
data at each 
facility during a 
four-week 
period. Data 
collected 
included times 
locations, 
indications and 
initial settings 
for NIV 
initiation and 
discontinuation. 
Patient 
characteristics, 
ABGs upon 
initiation, goals 
of care (code 
status) specialty 
of ordering 
provider, and 
survival status 
were also 
recorded. 
Wide variability in 
NIV use among the 
11 tertiary care 
centers studied.  
This variation 
could be related to 
lack of knowledge 
or familiarity with 
clinical practice 
guidelines. COPD 
and pulmonary 
edema were the 
two most common 
diagnoses for 
which NIV was 
initiated and was 
associated with 
relativity fewer 
intubations and 
lower mortality 
rates. Patients 
receiving NIV for 
ARF secondary to 
pneumonia had a 
higher rate of 
intubation than the 
previous two 
diagnoses. 
Level VI 
Single 
descriptive 
qualitative 
study 
Descriptive study 
with multiple 
variables at play. 
Provider 
knowledge, and 
location within 
the facility 
factored into the 
choice and 
timing of NIV 
Yes. 
Supports NIV 
as method to 
reduce 
intubation 
Esquinas, A. 
M., et al. 
correspondence 
Correspondence 
regarding ED 
This was not a 
research article, 
rather discussion 
Discussion 
between two 
groups 
El-Khatib et al. had 
investigated the 
percentage of use 
Level VII 
professional 
correspondence 
Although this 
article documents 
the 
Yes. This 
supports the 
need for 
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with El-Khatib, 
M. F., et al., 
(2014) 
protocols and use 
of NIV 
following an 
investigation 
into NIV use in 
Lebanese EDs 
interested in the 
more 
appropriate use 
of NIV in the 
ED environment 
of NIV in Lebanese 
EDs and found 
only 43% had some 
form of protocol 
for the use of NIV. 
Esquinas et al. 
called for 
investigation into 
the structure, 
resources and 
staffing of EDs, as 
well as guidelines 
for indication of 
NIV based on 
etiology, equipment 
used, and training 
of staff in 
successful 
application 
of expert 
opinions 
correspondence 
between these 
groups of 
providers, valid 
concerns are 
raised that should 
be considered in 
the development 
of a NIV 
protocol. 
protocols and 
adequate 
training of staff 
and providers 
in NIV use. 
Keenan, S. P., 
et al., (2011) 
Clinical practice 
guidelines 
An 18-member 
panel of 
clinicians 
reviewed 146 
RCTs 
investigating 
NIV. The panel 
was formed by 
the Canadian 
Critical Trials 
group and 
Canadian 
Critical Care 
Systematic 
review and 
compilation of 
NIV guidelines 
NIV was shown to 
reduce the need for 
intubation and 
hospital mortality. 
Insufficient 
evidence for 
support with 
asthma. 
Lack of RCTs for 
CAP with no 
history of 
respiratory disease 
and NIV. 
Level I 
Systematic 
review and 
practice 
guidelines 
Global studies 
investigated. The 
research supports 
use of NIV in 
COPD and 
cardiogenic 
pulmonary 
edema. Use of 
NIV in patients 
ARF may be 
trialed, but 
insufficient study 
support for 
recommendation. 
Yes. 
This supports 
NIV in two 
populations, 
COPD and 
cardiogenic 
pulmonary 
edema. At time 
of study, lack 
of evidence for 
use in asthma 
or pneumonia 
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Society NIV 
Guidelines 
Acknowledge that 
the possibility of 
benefit for ARF 
without COPD may 
exist, but data had 
not been collected 
to support this at 
the time of the 
study. 
 Kikichi, T. et 
al., (2011) 
Comparison of 
protocol-based 
noninvasive 
positive-pressure 
ventilation 
(pNPPV) use in 
the ED with 
individual 
physician directed 
NPPV (iNPPV) 
74 patients with 
ARF seen in the 
ED of one 
facility 
pNPPV protocol 
was developed. 
Data on 37 
patients with 
ARF treated 
with iNPPV was 
collected before 
protocol 
implementation, 
and compared 
with post 
implementation 
application of 
pNPPV for 37 
patients with 
ARF. 
 
The time to 
intubation was 
reduced in the 
protocol-based 
NPPV group and 
hospital mortality 
was significantly 
lower.  LOS was 
shorter though not 
statistically 
significant. 
Level VI 
Single 
qualitative 
study 
Single facility 
study with 
relatively small 
sample. 
Yes. This 
supports the 
creation of a 
protocol for 
NIV rather than 
leaving 
management up 
to individual 
providers 
without 
guidelines. 
Lim, W. J., et 
al. (2012)  
Determination of 
the efficacy of 
NPPV in adults 
with severe acute 
asthma in 
comparison to 
usual medical 
Five studies 
involving 206 
participants 
were reviewed 
Comparison of 
mortality and 
tracheal 
intubation rates, 
as well as 
changes in blood 
gases and LOS 
The lack of studies 
contributes to 
continued 
controversy 
regarding NPPV in 
asthma patients 
Level I 
systematic 
review with 
only five 
studies found 
to include in 
review 
Very small 
sample despite 
being a review of 
literature. 
Contradictory 
results continue 
to flame the 
Yes. Protocol 
should exclude 
asthma for NIV 
use. 
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care with respect 
to mortality, 
tracheal 
intubation, 
changes in blood 
gases, and LOS 
controversy 
regarding NPPV 
for asthma. 
Liu, Y. J., 
Zhao, J., Tang, 
H., (2016) 
Investigation of 
the utility of 
NPPV 
intervention in 
patients with ARF 
12 studies with a 
total of 963 
patients were 
examined 
Assessment of 
the effectiveness 
of NPPV versus 
conventional 
mechanical 
ventilation 
and/or non-
ventilation 
therapy, 
mortality rates, 
and LOS in ICU 
and hospital  
Usage of NPPV 
was associated with 
significantly 
decreased 
intubation and ICU 
mortality rates, but 
did not influence 
the hospital 
mortality rate, or 
ICU or hospital 
LOS. 
Level I meta-
analysis of 
studies  
Sample size and 
characteristics 
support the 
validity of the 
meta-analysis 
Yes. 
Further support 
for reduction of 
intubation rates 
Luo, Z., et al., 
(2018) 
Comparison of 
High-intensity 
versus low-
intensity NPPV in 
acute 
exacerbation of 
COPD 
(AECOPD) 
600 patients 
with AECOPD 
recruited in 27 
respiratory units 
in university 
hospitals in 
China between 
December 2017 
and December 
2018  
Randomization 
of eligible 
participants into 
high and low 
intensity groups. 
Tracking of the 
need for 
endotracheal 
intubation, 
decrement of 
CO2 tension 2 
hours after 
therapy, as well 
as in-house, 28-
day and 90-day 
Study results not 
yet available at the 
time of publishing 
Level II Well 
designed RCT 
This seems to be 
a well-designed 
study, and the 
results could 
inform a NPPV 
protocol, but 
those results are 
not yet available. 
No results to 
inform project 
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mortality rates 
will be 
documented. 
Meeder, A. M., 
Tjan, D., H. T., 
van Zanten, A. 
R., (2016) 
Assessment of 
rates and 
predictors of 
NPPV failure and 
comparison 
hospital outcomes 
of patients with 
NPPV failure and 
those intubated 
without NPPV 
trial 
The  records of 
40 ARF patients 
treated with 
NPPV and 40 
primary 
intubation 
patients in an 
ICU in the 
Netherlands 
A retrospective 
observational 
study using data 
from patients 
with ARF 
admitted to ICU 
from 2013-2014. 
All NPPV 
patients were 
evaluated and a 
sample of 
primarily 
intubated 
patients were 
selected for 
comparison of 
survival rates 
and risk factors. 
Patients with ARF 
who fail NPPV 
have worse 
outcomes than 
those with 
successful NPPV.  
NPPV failure 
patients do not 
have improved 
outcomes over 
primarily intubated 
patients. A 
prospective trial of 
NPPV is warranted 
in ARF. 
Level IV 
retrospective 
observational 
case-control 
study 
Single center 
study. Would 
need replicated 
studies for 
increased validity 
Yes. 
NPPV 
significantly 
reduces need 
for intubation 
and a trial with 
failed NPPV 
does not impact 
outcomes. 
 
Ni, Y. N., 
Wang, T., Yu, 
H., Liang, B. 
M., Liang, Z. 
A., (2017) 
Determine the 
effect of sedation 
and/or analgesia 
as rescue during 
NPPV in patients 
with interface 
intolerance after 
extubation 
80 patients 
placed on NPPV 
post extubation 
with 
documented 
interface 
intolerance were 
included. 
Patients studied 
were admitted to 
7 ICUs of one 
West China 
41 of 80 patients 
received 
sedation and/or 
analgesia during 
the NPPV 
therapy.  
The patients 
receiving sedation 
and/or analgesia 
evidenced a 
decrease in 
respiratory failure 
(15% vs. 38%), and 
mortality rate (7% 
vs. 33%), and 
length of ICU stay 
after extubation. 
Level IV well-
designed case-
control study. 
A retrospective 
study of the 
effect of 
analgesia on 
NPPV 
tolerance. 
Relatively small 
sample of 80 
patients in one 
facility in China. 
 
Yes. 
Sedation or 
analgesia could 
be included in 
the NIV 
protocol for 
interface 
intolerance 
during 
weaning. 
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facility between 
December 2014 
and August 
2016. 
Osadnik, C.R., 
et al. (2017) 
Comparison of 
the efficacy of 
NIV versus no 
mechanical 
ventilation in 
adults with acute 
hypercapnic 
respiratory failure 
(AHRF) due to 
AECOPD 
1264 patients 
from 17 clinical 
trials 
Evaluation of 
mortality rates, 
intubation rates, 
and LOS were 
compared 
through the 
studies for 
AECOPD 
patients 
receiving NIV 
and those who 
did not. 
The risk of death 
was reduced by 
46% and the 
necessity of 
intubation was 
reduced by 65% in 
NIV patients. NIV 
patients showed an 
average 3.4 days 
shorter LOS than 
those not receiving 
NIV. 
Level I 
Systematic 
review of 17 
clinical trials 
Though the 
findings scored 
as moderate on 
the GRADE 
criteria, the 
number of 
patients included 
and the number 
of facilities 
studied support 
the 
generalizability 
of the results. 
Yes. 
Support for 
NIV over 
withholding of 
the therapy 
 
Ouellette, D. 
R., et al. 
(2017) 
Development of 
practice 
guidelines and 
protocols for 
mechanical 
ventilation 
Multiple studies 
were included to 
answer three 
PICO questions 
 
1st Should SBT 
be conducted 
with or without 
inspiratory 
pressure 
augmentation? 
2nd does 
minimizing 
sedation impact 
duration of 
ventilation? 
3rd How does 
NIV compare 
with no NIV 
post extubation 
in duration of 
1st For patients 
ventilated more 
than 24 hours, 
initial SBT should 
be conducted with 
inspiratory pressure 
augmentation 
(CPAP) rather than 
without. 
2nd For patients 
ventilated more 
than 24 hours, 
protocols for 
minimal sedation 
should be 
implemented 
Level I  
Clinical 
practice 
guideline post 
Meta-analysis 
of available 
literature 
Although this is a 
joint clinical 
practice 
guideline from 
the American 
College of Chest 
Physicians and 
the American 
Thoracic Society, 
each of the three 
questions was 
addressed by 
review of 5-6 
clinical trials. 
Yes. 
These are 
official 
guidelines to 
inform the 
protocol 
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ventilation, 
extubation 
success, 
duration of ICU 
stay and short or 
long-term 
mortality? 
 
3rd For patients at 
high risk for 
extubation failure, 
preventative NIV is 
recommended post 
extubation. 
Scala, R., 
Pisani, L., 
(2018) 
Update on 
evidence-based 
usefulness of 
NPPV in ARF 
116 articles 
listed in 
references 
A qualitative 
review and 
analysis of 
studies 
NPPV can be 
successful in 
reducing the 
intubation rate but 
should be carried 
out by skilled 
teams that can 
recognize failure 
and the need for 
intubation, or 
discussion with 
patient and family 
regarding wishes 
for DNI status early 
in treatment. 
Level V 
A qualitative 
review 
No specific 
recommendations 
or changes 
provided for an 
NIV protocol. 
Discussion of the 
need for skilled 
practitioners to 
know when and 
which NIV to 
use, which 
interface, and 
which settings. 
No, the 
effectiveness of 
NIV is not 
discussed.  The 
need for skilled 
practitioners is 
the focus of the 
study. 
 
Simonelli, C., 
Paneroni, M., 
Vitacca, M., 
(2013) 
Description of 
implementation of 
a standardized 
protocol to NIV 
adaptation for 
patients with 
chronic 
respiratory 
disease, and 
evaluation of the 
201 chronic 
respiratory 
disease patients 
were enrolled in 
cardiopulmonary 
rehabilitation 
service (CPRS) 
over 16 months 
in one Italian 
hospital 
Measurement of 
the effectiveness 
of PT in 
management of 
NIV/CPAP  
PT may reduce the 
workload of nurses 
and physicians in 
management of 
NIV/CPAP. 
Level VI 
One qualitative 
study in one 
Italian hospital 
Evidence from a 
single study. The 
role of 
physiotherapist is 
more commonly 
used in rehab 
setting rather 
than acute care. 
No. The facility 
does not have a 
physiotherapist 
available for 
this role. 
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physiotherapist 
(PT) role and 
time-consumption 
Stefan, M., S., 
et al., (2018)  
Comparison of 
patients 
hospitalized with 
pneumonia 
treated with NIV 
and invasive 
mechanical 
ventilation (IMV) 
3971 medical 
records mined 
from the Cerner 
EHR system  
A retrospective- 
cohort study 
comparing ARF 
pneumonia 
patients placed 
on NIV or IMV 
or both during 
their course of 
treatment 
Initial NIV was 
associated with 
better survival 
among the 
subgroup of 
patients 
hospitalized with 
pneumonia who 
had COPD or heart 
failure. Patients 
who failed NIV had 
a high in-hospital 
mortality, 
emphasizing the 
importance of 
careful 
management of 
NIV. 
Level IV 
Retrospective 
cohort study 
Very large 
sample from a 
wide variety of 
locations in the 
United States 
Yes. 
NIV improved 
survival rate for 
pneumonia. 
Vargas, F., et 
al., (2017) 
Assessment of the 
efficacy of early 
NIV in decreasing 
respiratory failure 
after extubation in 
patients with 
chronic 
respiratory 
disorders 
144 
mechanically 
ventilated 
patients with 
chronic 
respiratory 
disorder in six 
French ICUs 
between January 
2010 and June 
2011 
Prospective 
randomized 
multicenter 
controlled trials 
were randomly 
assigned to 
receive NIV 
post extubation 
or conventional 
oxygen therapy. 
72 patients were 
assigned to each 
Respiratory failure 
for the NIV group 
was 8.5% 
compared to 27.8% 
for the oxygen 
group. Reintubation 
occurred in 8.5% of 
NIV and 18.1 % of 
oxygen group. 
Mortality rates did 
not differ 
significantly 
Level II  
A well-
designed 
multicenter 
RCT 
144 patients from 
six facilities were 
included in the 
study. The 
facilities were all 
in France and 
should be 
supported by 
replication in 
other countries. 
Yes. NIV is 
supported as 
reducing 
respiratory 
failure in 
chronic 
respiratory 
disease. 
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group. 
Respiratory 
failure after 
extubation, 
reintubation, 
ICU mortality 
and 90-day 
mortality were 
tracked for both 
groups. 
between the 
groups. 
*Note:  Melnyk’s Level of Evidence (LOE) Pyramid is required for appraising the level of evidence.  This appendix is formatted in landscape 
orientation.  
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Appendix: B Noninvasive Ventilation (NIV) Pilot Protocol 
Initial patient assessment of the need for NIV 
Inclusion       Exclusion 
Yes 
 
 
Monitor   
    Initial Settings      
 
 
 
  
  
 
NIV Failure                   Yes 
 
 
Adjustment to improve patient compliance  
   
 
 
              
No 
 
 
 
f 
12-hour rest on NIV if tolerated                 Monitor for signs of fatigue 
          
  
  
  
                   Yes 
                                            
 
      No
                                                                
 
 
*Goal O2 saturation may vary in COPD patients.  Adjust per provider orders or patient baseline  
Acute COPD, CPE, or hypercapnic respiratory failure 
(pH< 7.35 and PaCO2>45 mmHg)  
Hypoxemia SpO2< 90% or PaO2< 80 *                                                                        
Clinical signs of impending intubation, including but not limited to: 
Tachypnea of ≥25 breaths/minute, increased respiratory effort or 
fatigue, dyspnea, accessory muscle use, intercostal retractions, or 
paradoxical abdominal movement. 
Apnea 
Unable to cooperate 
Need for airway protection (coma., seizures vomiting) 
SBP < 90mm HG 
Recent facial, esophageal, or gastric surgery or trauma 
Facial deformities preventing effective seal 
Inability to clear secretions 
No                                                        Yes 
C
o
n
sid
er in
tu
b
a
tio
n
 
Obtain orders for NIV protocol 
Oronasal mask for pressure support ventilation 
Titrate FIO2 for SpO2> 90% * 
Telemetry with SaO2 monitor 
Patient comfort, dyspnea, accessory muscle use 
Respiratory rate and SpO2 
Heart Rate & blood pressure 
Patient-ventilator synchrony 
Mask leak 
Arterial Blood Gases (ABGs) at 60 minutes 
Monitor for signs of gastric distension 
Assess drying of eyes  
Assess for facial skin breakdown 
 
Coaching 
Mask fit; Nasal versus oronasal 
Inspiratory and expiratory pressure 
levels 
FIO2 level 
Sedation 
Continuous versus intermittent use 
 
Hemodynamic instability 
Decreased mental status 
Respiratory rate ≥ 25 
Decreasing pH and increasing PaCO2 
Inability to maintain SpO2> 90% * 
Inability to tolerate mask 
Inability to manage secretions 
Patient preference 
Repeat ABG in 12 hours and every 24 
hours if stable 
Continue monitoring for evidence of 
NIV failure 
Titrate inspiratory and expiratory 
positive pressure as tolerated to maintain 
FIO2 for SpO2 ≥90% 
 
Resume NIV for the following: 
Respiratory rate > 25/minute 
Increased dyspnea 
Increased use of accessory muscles 
Patient request 
Trials off NIV as tolerated 
Free from NIV for 24 
hours without fatigue 
Discontinue NIV 
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Appendix C: NIV Audit Tool 
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Appendix D: Letter of Permission from Facility of Study 
Brownwood Regional 
M E D I C A L C E N T E R 
January 11, 2019 
Liberty University 
ATTENTION: FAITH STERLING 
C/O Dr. Kopis 
1971 University Blvd. 
Lynchburg, VA 24515 
Re: Janise Tinsman DNP 
To Whom it May Concern: 
My name is Misty Woodard. I am the Facility Compliance Officer and Director of Quality Management and Regulatory Compliance for 
Brownwood Regional Medical Center in Brownwood, Texas. Janise Tinsman is a student enrolled in your DNP program and is slated to begin her 
course work on January 14, 2019. l, along with William Loyd, will serve as her preceptors for the program. 
Please accept this written notice permitting Ms. Tinsman to perform duties pursuant to your NonExclusive Student Affiliation Agreement with 
our facility. On behalf of our facility, Mr. Loyd and I are excited to begin work on reducing mortality and improving the overall care of the 
pneumonia patient population. 
Ms. Tinsman will be performing medical record reviews for data collection, working with a team to implement protocols and order sets, and will 
be leading a collaborative for a successful implementation of these new protocols. 
If you have any further needs, please do not hesitate to contact myself or Mr. Loyd at the contact information below. 
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Sincerely, 
Misty D. Woodard, RN, BSN 
FCO, Director of QMRC 
Misty_Woodard@BRMC-Cares.com 
William Loyd, BBA, SHA 
Director of Operations 
William_Loyd@BRMC-Cares.com 
325-649-3315 
 1501 Burnet Drive Brownwood, TX 76801 325 646 8541 • brmc-cares.com 
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Appendix E: Permission to Use Iowa Model 
Permission to Use The Iowa Model Revised: Evidence-Based 
Practice to Promote Excellence in Health Care 
K 
Kimberly Jordan - University of Iowa Hospitals and Clinics <noreply@qualtrics-
survey.com> 
 
 
Reply all| 
Sun 1/27, 6:32 PM 
Tinsman, Janise  
Inbox 
Action Items 
You have permission, as requested today, to review and/or reproduce The Iowa Model Revised: 
Evidence-Based Practice to Promote Excellence in Health Care. Click the link below to open. 
  
The Iowa Model Revised: Evidence-Based Practice to Promote Excellence in Health Care 
  
Copyright is retained by University of Iowa Hospitals and Clinics. Permission is not granted 
for placing on the internet. 
 
Citation: Iowa Model Collaborative. (2017). Iowa model of evidence-based practice: 
Revisions and validation. Worldviews on Evidence-Based Nursing, 14(3), 175-182. 
doi:10.1111/wvn.12223 
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In written material, please add the following statement: 
Used/reprinted with permission from the University of Iowa Hospitals and 
Clinics, copyright 2015. For permission to use or reproduce, please contact the 
University of Iowa Hospitals and Clinics at 319-384-9098. 
Please contact UIHCNursingResearchandEBP@uiowa.edu or 319-384-9098 with questions. 
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Appendix F:.CITI Training Certificate 
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Appendix G: Historical Results 
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Appendix H: Protocol Results 
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